Myocardial Extracellular Volume Expansion and the Risk of Recurrent Atrial Fibrillation After Pulmonary Vein Isolation

被引:67
作者
Neilan, Tomas G. [1 ,2 ]
Mongeon, Francois-Pierre [1 ,3 ]
Shah, Ravi V. [1 ,2 ]
Coelho-Filho, Otavio [1 ,4 ]
Abbasi, Siddique A. [1 ]
Dodson, John A. [5 ]
McMullan, Ciaran J. [6 ]
Heydari, Bobak [1 ]
Michaud, Gregory F. [1 ]
John, Roy M. [1 ]
Blankstein, Ron [1 ]
Jerosch-Herold, Michael [7 ]
Kwong, Raymond Y. [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Div Radiol,Cardiac MR PET CT Program, Boston, MA 02114 USA
[3] Univ Montreal, Montreal Heart Inst, Dept Med, Montreal, PQ, Canada
[4] State Univ Campinas UNICAMP, Dept Internal Med, Campinas, SP, Brazil
[5] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Aging, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Nephrol, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
cardiac magnetic resonance; myocardial fibrosis; T-1; measurements; LEFT-VENTRICULAR MASS; CARDIAC MAGNETIC-RESONANCE; DIASTOLIC DYSFUNCTION; MATRIX EXPANSION; T1; MEASUREMENTS; HEART-FAILURE; FIBROSIS; ASSOCIATION; ECHOCARDIOGRAPHY; QUANTIFICATION;
D O I
10.1016/j.jcmg.2013.08.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study tested whether myocardial extracellular volume (ECV) is increased in patients with hypertension and atrial fibrillation (AF) undergoing pulmonary vein isolation and whether there is an association between ECV and post-procedural recurrence of AF. BACKGROUND Hypertension is associated with myocardial fibrosis, an increase in ECV, and AF. Data linking these findings are limited. T-1 measurements pre-contrast and post-contrast in a cardiac magnetic resonance (CMR) study provide a method for quantification of ECV. METHODS Consecutive patients with hypertension and recurrent AF referred for pulmonary vein isolation underwent a contrast CMR study with measurement of ECV and were followed up prospectively for a median of 18 months. The endpoint of interest was late recurrence of AF. RESULTS Patients had elevated left ventricular (LV) volumes, LV mass, left atrial volumes, and increased ECV (patients with AF, 0.34 +/- 0.03; healthy control patients, 0.29 +/- 0.03; p < 0.001). There were positive associations between ECV and left atrial volume (r = 0.46, p < 0.01) and LV mass and a negative association between ECV and diastolic function (early mitral annular relaxation [E'] r = -0.55, p < 0.001). In the best overall multivariable model, ECV was the strongest predictor of the primary outcome of recurrent AF (hazard ratio: 1.29; 95% confidence interval: 1.15 to 1.44; p < 0.0001) and the secondary composite outcome of recurrent AF, heart failure admission, and death (hazard ratio: 1.35; 95% confidence interval: 1.21 to 1.51; p < 0.0001). Each 10% increase in ECV was associated with a 29% increased risk of recurrent AF. CONCLUSIONS In patients with AF and hypertension, expansion of ECV is associated with diastolic function and left atrial remodeling and is a strong independent predictor of recurrent AF post-pulmonary vein isolation. (C) 2014 by the American College of Cardiology Foundation
引用
收藏
页码:1 / 11
页数:11
相关论文
共 47 条
[1]   QUANTITATIVE STRUCTURAL-ANALYSIS OF THE MYOCARDIUM DURING PHYSIOLOGICAL GROWTH AND INDUCED CARDIAC-HYPERTROPHY - A REVIEW [J].
ANVERSA, P ;
RICCI, R ;
OLIVETTI, G .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 7 (05) :1140-1149
[2]   LV Mass Assessed by Echocardiography and CMR, Cardiovascular Outcomes, and Medical Practice [J].
Armstrong, Anderson C. ;
Gidding, Samuel ;
Gjesdal, Ola ;
Wu, Colin ;
Bluemke, David A. ;
Lima, Joao A. C. .
JACC-CARDIOVASCULAR IMAGING, 2012, 5 (08) :837-848
[3]   The Relationship of Left Ventricular Mass and Geometry to Incident Cardiovascular Events [J].
Bluemke, David A. ;
Kronmal, Richard A. ;
Lima, Joao A. C. ;
Liu, Kiang ;
Olson, Jean ;
Burke, Gregory L. ;
Folsom, Aaron R. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (25) :2148-2155
[4]   Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease [J].
Brilla, CG ;
Funck, RC ;
Rupp, H .
CIRCULATION, 2000, 102 (12) :1388-1393
[5]   Quantification of Diffuse Myocardial Fibrosis and Its Association With Myocardial Dysfunction in Congenital Heart Disease [J].
Broberg, Craig S. ;
Chugh, Sumeet S. ;
Conklin, Catherine ;
Sahn, David J. ;
Jerosch-Herold, Michael .
CIRCULATION-CARDIOVASCULAR IMAGING, 2010, 3 (06) :727-734
[6]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[7]   The effect of cardiac resynchronization on morbidity and mortality in heart failure [J].
Cleland, JGF ;
Daubert, J ;
Erdmann, E ;
Freemantle, N ;
Gras, D ;
Kappenberger, L ;
Tavazzi, L ;
Cleland, JGF ;
Daubert, JC ;
Erdmann, E ;
Gras, D ;
Kappenberger, L ;
Klein, W ;
Tavazzi, L ;
Poole-Wilson, PA ;
Rydén, L ;
Wedel, H ;
Wellens, HJJ ;
Uretsky, B ;
Thygesen, K ;
Böcker, D ;
Marijianowski, MMH ;
Freemantle, N ;
Calvert, MJ ;
Christ, G ;
Fruhwald, F ;
Hofmann, R ;
Krypta, A ;
Leisch, F ;
Pacher, R ;
Rauscha, F ;
Tavernier, R ;
Thomsen, PEB ;
Boesgaard, S ;
Eiskjær, H ;
Esperen, GT ;
Haarbo, J ;
Hagemann, A ;
Korup, E ;
Moller, M ;
Mortensen, P ;
Sogaard, P ;
Vesterlund, T ;
Huikuri, H ;
Niemelä, KI ;
Toivonen, L ;
Bauer, F ;
Cohen-Solal, A ;
Crocq, C ;
Djiane, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (15) :1539-1549
[8]   Role of Transcytolemmal Water-Exchange in Magnetic Resonance Measurements of Diffuse Myocardial Fibrosis in Hypertensive Heart Disease [J].
Coelho-Filho, Otavio R. ;
Mongeon, Francois-Pierre ;
Mitchell, Richard ;
Moreno, Heitor, Jr. ;
Nadruz, Wilson, Jr. ;
Kwong, Raymond ;
Jerosch-Herold, Michael .
CIRCULATION-CARDIOVASCULAR IMAGING, 2013, 6 (01) :134-141
[9]   Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003
[10]   Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients [J].
Díez, J ;
Querejeta, R ;
López, B ;
González, A ;
Larman, M ;
Ubago, JLM .
CIRCULATION, 2002, 105 (21) :2512-2517